🔎 Today’s Daily Sift: Longevity Longevity has crossed the border from wellness trend into geopolitical technology race. Today’s signal is unmistakable: Aging is no longer being framed as destiny. It is being reframed as infrastructure failure. Silicon Valley capital, AI labs, biotech founders, and preventative medicine networks are converging on one thesis: Biological age is becoming programmable. The old biotech model targeted single diseases. The new model targets aging itself as the upstream operating system. The frontier today is partial cellular reprogramming. Yamanaka factor research is moving from speculative science into regulated human pathways. Companies are testing therapies designed to restore youthful cellular function without resetting cell identity entirely. AI is accelerating the process dramatically. Machine learning systems are now identifying longevity compounds faster than traditional pharma pipelines. The deeper pattern: AI is becoming the microscope fo...